Citation 72803

UBILLAS,R: JOLAD,SD: BRUENING,RC: KERNAN,MR: KING,SR: SESIN,DF: BARRETT,M: STODDART,CA: FLASTER,T: KUO,J: AYALA,F: MEZA,E: CASTANEL,M: MC MEEKIN,D: ROZHON,E: TEMPESTA,MS: BARNARD,D: HUFFMAN,J: SMEE,D: SIDWELL,R: SOIKE,K: BRAZIER,A: SAFRIN,S: ORLANDO,R: KENNY,PTM: BEROVA,N: NAKANISHI,K:. (1994). SP-303, AN ANTIVIRAL OLIGOMERIC PROANTHOCYANIDIN FROM THE LATEX OF CROTON LECHLERI (SANGRE DE DRAGO).. 1(2)

Citation Details

TitleSP-303, AN ANTIVIRAL OLIGOMERIC PROANTHOCYANIDIN FROM THE LATEX OF CROTON LECHLERI (SANGRE DE DRAGO).
AuthorsUBILLAS,R: JOLAD,SD: BRUENING,RC: KERNAN,MR: KING,SR: SESIN,DF: BARRETT,M: STODDART,CA: FLASTER,T: KUO,J: AYALA,F: MEZA,E: CASTANEL,M: MC MEEKIN,D: ROZHON,E: TEMPESTA,MS: BARNARD,D: HUFFMAN,J: SMEE,D: SIDWELL,R: SOIKE,K: BRAZIER,A: SAFRIN,S: ORLANDO,R: KENNY,PTM: BEROVA,N: NAKANISHI,K:
Year1994
Volume1
Issue2

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Croton lechleri (EUPHORBIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
2
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
3Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR
SP-303
None
4
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
WEAK ACTIVITY
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SP-303
INACTIVE
6
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
WEAK ACTIVITY
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
8
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
9
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
10
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
WEAK ACTIVITY
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
12
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
14
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
WEAK ACTIVITY
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
16
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
17
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
18
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
20
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
21
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
22
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
23
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
24
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
25
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
26
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
27
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
28
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
29
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
INACTIVE
30
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
31
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
32
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
33
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
ACTIVE
34
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
EQUIVOCAL
35
ANTIVIRAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SP-303
WEAK ACTIVITY
36
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
37
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
38
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
39
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
40
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
41
TOXICITY ASSESSMENT(QUANTITATIVE)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
.
42
TOXIC EFFECT(GENERAL)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
INACTIVE
43
TOXIC EFFECT(GENERAL)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
ACTIVE
44
TOXIC EFFECT(GENERAL)
PHARMACOLOGY OF COMPOUND - IN VIVO
SP-303
INACTIVE
Show SPARQL Queries (1)